Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2025
FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease
29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...
Posted by Michael Wonder on 07 Dec 2020
Update on funding decision for two new diabetes medicines
7 December 2020 - PHARMAC would like to thank everyone who has provided feedback to date on a proposal to ...
Posted by Michael Wonder on 06 Dec 2020
How COVID-19 vaccines are being approved in Canada
5 December 2020 - Measures have been taken to expedite the approval process. ...
Posted by Michael Wonder on 06 Dec 2020
The elderly vs. essential workers: who should get the coronavirus vaccine first?
5 December 2020 - The C.D.C. will soon decide which group to recommend next, and the debate over the trade-offs is ...
Posted by Michael Wonder on 06 Dec 2020
HHS’s Alex Azar says Pfizer vaccine could receive green light within days
6 December 2020 - The top U.S. health official said the federal government could authorise Pfizer’s COVID-19 vaccine within days ...
Posted by Michael Wonder on 06 Dec 2020
BIO to file lawsuit today to block Trump international drug pricing policy
4 December 2020 - The Biotechnology Innovation Organization will file a lawsuit today to block implementation of President Trump’s new ...
Posted by Michael Wonder on 06 Dec 2020
Government promises independent PHARMAC review after Labour MPs veto Health Select Committee inquiry
3 December 2020 - National MPs have lashed out at Labour for voting against a politician-led inquiry into PHARMAC but ...
Posted by Michael Wonder on 06 Dec 2020
Strengthening Australia's immunisation program
3 December 2020 - The Australian Government is continuing to improve Australia’s world leading vaccination program through the Australian Immunisation Register ...
Posted by Michael Wonder on 05 Dec 2020
FDA approves weight management drug for patients aged 12 and older
4 December 2020 - The U.S. FDA has approved Saxenda (liraglutide) for chronic weight management among patients aged 12 and older ...
Posted by Michael Wonder on 05 Dec 2020
Pfizer slashes its original COVID-19 vaccine rollout target after supply-chain obstacles
4 December 2020 - Pfizer expects to ship half of the COVID-19 vaccines it originally planned for this year because ...
Posted by Michael Wonder on 04 Dec 2020
Novo Nordisk files for US FDA regulatory approval of once-weekly semaglutide 2.4 mg for weight management
4 December 2020 - Novo Nordisk today announced the submission of a new drug application to the US FDA for subcutaneous ...
Posted by Michael Wonder on 04 Dec 2020
BioCryst announces FDA approval of Orladeyo (berotralstat), first oral, once-daily therapy to prevent attacks in hereditary angioedema patients
3 December 2020 - Significant and sustained reduction in HAE attacks. ...
Posted by Michael Wonder on 04 Dec 2020
ICER opens nominations for new members of its voting panels
2 December 2020 - Independent panel members debate the evidence on the effectiveness and value of new drugs and other ...
Posted by Michael Wonder on 04 Dec 2020
Access Consortium statement on COVID-19 vaccines evidence
4 December 2020 - The medicine regulators from Australia, Canada, Singapore, Switzerland and the United Kingdom (Access Consortium) have discussed the ...
Posted by Michael Wonder on 04 Dec 2020
enGene receives fast track designation for EG-70 for the treatment of non-muscle invasive bladder cancer
3 December 2020 - enGene announced today that the U.S. FDA has granted fast track designation to enGene for EG-70, the ...
Posted by Michael Wonder on 04 Dec 2020
COVID-19 vaccine will be free of charge, 1 million inoculations set for January, French PM say
3 December 2020 - After the vaccination of an initial 1 million people in January an additional 14 million at ...